M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 34 SEK
Market Cap: 667.4m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Magle Chemoswed Holding AB
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
M
Magle Chemoswed Holding AB
STO:MAGLE
Additional Paid In Capital
kr118m
CAGR 3-Years
6%
CAGR 5-Years
26%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Additional Paid In Capital
kr2.6B
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Additional Paid In Capital
kr7.6B
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Additional Paid In Capital
kr2.3B
CAGR 3-Years
230%
CAGR 5-Years
109%
CAGR 10-Years
85%
G
Genovis AB
STO:GENO
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Magle Chemoswed Holding AB
Glance View

Market Cap
667.4m SEK
Industry
Life Sciences Tools & Services

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
85.47 SEK
Undervaluation 60%
Intrinsic Value
Price
M

See Also

What is Magle Chemoswed Holding AB's Additional Paid In Capital?
Additional Paid In Capital
118m SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Additional Paid In Capital amounts to 118m SEK.

What is Magle Chemoswed Holding AB's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
26%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Magle Chemoswed Holding AB have been 6% over the past three years , 26% over the past five years .

Back to Top